Hybrid Capture Human Papillomavirus Testing as an Adjunct to the Follow‐Up of Patients with ASCUS and LGSIL Pap Smears: A Study of a Screening Population

OBJECTIVES: We set out to evaluate Hybrid Capture (Digene Corporation, Silver Spring, MD) testing for human papillomavirus (HPV) in the management of a screening population with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LGSIL). METHODS: A total of 619 patients with ASCUS or LGSIL Papanicolaou smears were tested for high-risk HPV types. They then were followed at 6-month intervals …